OTCQX
CURLF

Curaleaf Holdings Inc

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

Curaleaf Holdings Inc Stock Price

Vitals

Today's Low:
$4.52
Today's High:
$5.335
Open Price:
$5.26
52W Low:
$2.19
52W High:
$7.9
Prev. Close:
$5.24
Volume:
1638914

Company Statistics

Market Cap.:
$2.05 billion
Book Value:
1.715
Revenue TTM:
$1.38 billion
Operating Margin TTM:
-1.62%
Gross Profit TTM:
$687.59 million
Profit Margin:
-28.18%
Return on Assets TTM:
-0.4%
Return on Equity TTM:
-24.65%

Company Profile

Curaleaf Holdings Inc had its IPO on under the ticker symbol CURLF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Curaleaf Holdings Inc has a staff strength of 0 employees.

Stock update

Shares of Curaleaf Holdings Inc opened at $5.26 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $4.52 - $5.34, and closed at $5.05.

This is a -3.63% slip from the previous day's closing price.

A total volume of 1,638,914 shares were traded at the close of the day’s session.

In the last one week, shares of Curaleaf Holdings Inc have increased by +31.51%.

Curaleaf Holdings Inc's Key Ratios

Curaleaf Holdings Inc has a market cap of $2.05 billion, indicating a price to book ratio of 2.3589 and a price to sales ratio of 2.5587.

In the last 12-months Curaleaf Holdings Inc’s revenue was $1.38 billion with a gross profit of $687.59 million and an EBITDA of $150.30 million. The EBITDA ratio measures Curaleaf Holdings Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Curaleaf Holdings Inc’s operating margin was -1.62% while its return on assets stood at -0.4% with a return of equity of -24.65%.

In Q1, Curaleaf Holdings Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 13.7%.

Curaleaf Holdings Inc’s PE and PEG Ratio

Forward PE
39.0625
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-0.54 per share while it has a forward price to earnings multiple of 39.0625 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Curaleaf Holdings Inc’s profitability.

Curaleaf Holdings Inc stock is trading at a EV to sales ratio of 3.6019 and a EV to EBITDA ratio of 15.7957. Its price to sales ratio in the trailing 12-months stood at 2.5587.

Curaleaf Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$3.36 billion
Total Liabilities
$544.74 million
Operating Cash Flow
$0
Capital Expenditure
$26.04 million
Dividend Payout Ratio
0%

Curaleaf Holdings Inc ended 2024 with $3.36 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $3.36 billion while shareholder equity stood at $1.23 billion.

Curaleaf Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $544.74 million in other current liabilities, in common stock, $-913936000.00 in retained earnings and $626.69 million in goodwill. Its cash balance stood at $115.81 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $523.94 million.

Curaleaf Holdings Inc’s total current assets stands at $599.41 million while long-term investments were $2.68 million and short-term investments were $0. Its net receivables were $45.77 million compared to accounts payable of $72.49 million and inventory worth $261.31 million.

In 2024, Curaleaf Holdings Inc's operating cash flow was $0 while its capital expenditure stood at $26.04 million.

Comparatively, Curaleaf Holdings Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$5.05
52-Week High
$7.9
52-Week Low
$2.19
Analyst Target Price
$

Curaleaf Holdings Inc stock is currently trading at $5.05 per share. It touched a 52-week high of $7.9 and a 52-week low of $7.9. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $3.47 and 200-day moving average was $3.56 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 3233.7% of the company’s stock are held by insiders while 27.9% are held by institutions.

Frequently Asked Questions About Curaleaf Holdings Inc

The stock symbol (also called stock or share ticker) of Curaleaf Holdings Inc is CURLF

The IPO of Curaleaf Holdings Inc took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$1568.75
-19.85
-1.25%
$3.68
0.05
+1.38%
$162.05
-6.05
-3.6%
$0.23
-0.02
-9.16%
$52.4
-3.97
-7.04%
$0.7
0
0%
$44.32
0.12
+0.27%
$1432.85
-50.35
-3.39%
$94.45
-0.08
-0.08%
Xpeng Inc (XPEV)
$18.65
0.17
+0.92%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through Domestic Operations and International Operations segments. The company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. In addition, it offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. Further, the company provides hemp-based CBD and cannabigerol products. The company was founded in 2010 and is headquartered in New York, New York.

Address

301 Edgewater Place, Wakefield, MA, United States, 01880